Global point of care
Afinion™ CRP is a rapid in vitro diagnostic test for quantitative determination of C-reactive protein (CRP) in human blood; helping reduce diagnostic uncertainty and guiding antibiotic decision making during your patient’s visit.1-3
A significantly increased CRP result may indicate the need for immediate antibiotic treatment. The CRP level decreases rapidly in response to effective therapy. A normal or moderately increased CRP may support a diagnosis of viral or self-limiting infection, which provides valuable information to prevent unnecessary antibiotic prescriptions.
Patient consultations can be carried out with confidence. The CRP Test Cartridge contains all reagents necessary for the measurement of C-reactive protein with 4 weeks room temperature storage (15-25°C).
The Afinion™ CRP test gives you reliable, highly-accurate results conveniently available when and where you need them.
| Afinion™ System Test | Code |
|---|---|
| Afinion™ CRP Assay | 1116787 Global |
| 1116789 Nordic | |
| 1116788 Japan | |
| 1116786 India | |
| Afinion™ CRP Control | 1116785 Global |
Learn how to use the Afinion™ Test System by watching our complete set of demo video modules.
See how you can improve patient outcomes with the Afinion™ 2 system — providing you with highly accurate results in minutes at the point of care.
ITV News reports on the O'Neill Review and features the point-of-care Afinion™ CRP test being used in primary care.
In less than 30 seconds, see how the Afinion™ 2 system can put highly accurate results in your hands in minutes.
See how we manufacture Afinion™ products in Oslo that are highly accurate and reliable every step, every time.
30 Years Pioneering CRP Point Of Care Testing - Afinion™ CRP
1. Smedemark SA, Aabenhus R, Llor C, Fournaise A, Olsen O, Jørgensen KJ. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care. Cochrane Database Syst Rev 2022;10(10):CD010130
2. OECD (2023), Embracing a One Health Framework to Fight Antimicrobial Resistance
3. Van Hecke O, Bjerrum L, Gentile I, Hopstaken R, Melbye H, Plate A, Verbakel JY, Llor C and Staiano A. Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care. Front Med 2023;10:1166742
Open access: https://doi.org/10.3389/fmed.2023.1166742
A Leader In Rapid Point-Of-Care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non-US Citizens. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
